Immunic (IMUX) Interest & Investment Income (2013 - 2026)
Immunic (IMUX) reported Interest & Investment Income of $760000.0 for Q1 2026, up 315.3% on a YoY basis from $183000.0 in Q1 2025, and up 285.79% sequentially from $197000.0 in Q4 2025.
Immunic (IMUX) Interest & Investment Income (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Interest & Investment Income data on file, last reported at $760000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 315.3% year-over-year to $760000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 32.23% YoY), and the FY2025 full-year result was $1.0 million, down 69.32% from the prior year.
- Interest & Investment Income climbed to $760000.0 in Q1 2026, from $197000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q1 2024 to a low of $7000.0 in Q1 2022.
- A 5-year average of $547411.8 and a median of $541000.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 11328.57% in 2023 and sank 84.58% in 2025, its largest moves.
- Tracing IMUX's Interest & Investment Income over 5 years: stood at $698000.0 in 2022, then fell by 22.49% to $541000.0 in 2023, then retreated by 20.7% to $429000.0 in 2024, then plunged by 54.08% to $197000.0 in 2025, then jumped by 285.79% to $760000.0 in 2026.
- Business Quant data shows IMUX's Interest & Investment Income at $760000.0 in Q1 2026, $197000.0 in Q4 2025, and $419000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Immunic | 420.10 Mn | 420.10 Mn | - | 760,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 760,000.00 |
| Dec 31, 2025 | 197,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 241,000.00 |
| Mar 31, 2025 | 183,000.00 |
| Dec 31, 2024 | 429,000.00 |
| Sep 30, 2024 | 776,000.00 |
| Jun 30, 2024 | 998,000.00 |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 541,000.00 |
| Sep 30, 2023 | 766,000.00 |
| Jun 30, 2023 | 968,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 698,000.00 |
| Sep 30, 2022 | 230,000.00 |
| Jun 30, 2022 | 106,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Dec 31, 2021 | 15,000.00 |
| Sep 30, 2021 | 10,000.00 |
| Jun 30, 2021 | 13,000.00 |